Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Oct 14, 2017; 23(38): 6962-6972
Published online Oct 14, 2017. doi: 10.3748/wjg.v23.i38.6962
Figure 4
Figure 4 The effects of a short course of rapamycin treatment on CD4+ and CD8+ regulatory T cell phenotypes. A: The dLNs of grafted animals were collected on day 11 and day 42 and regulatory CD4+ T cells were analyzed by flow cytometry. Different activation markers were studied (CD25+, ICOS+, Helios+) after gating on CD25+FOXP3+ among CD4+ cells. The results are expressed as the mean +/- SEM of the percentages of CD25+, ICOS+, and Helios+ or the MFI values for CD25, ICOS, and Helios; n = 4-5 rats/group. P-values are indicated when the differences between the two groups of rats are significant (aP ≤ 0.05, bP ≤ 0.01). MFI, mean fluorescence intensity; B: The ndLNs, dLNs and spleens of grafted animals were collected on day 11 and day 42 and the percentages of CD25+Foxp3+ regulatory CD8+ T cells were analyzed by flow cytometry. The MFI values of the activation markers (CD25, ICOS, and CTLA-4) are shown for the dLNs. The results are expressed as the mean +/- SEM. P-values are indicated when the differences between the two groups of rats are significant (aP ≤ 0.05, bP ≤ 0.01, cP ≤ 0.0001); C: The percentages of CD45RClow cells among CD8+ cells in the dLNs, ndLNs and spleens of grafted rats are shown. The results are expressed as the mean +/- SEM. P-values are indicated when the differences between the two groups of rats are significant (aP ≤ 0.05).